Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005844 · ClinicalTrials.gov registry record · Phase 1
Oxaliplatin in Treating Children With Advanced Solid Tumors
A Phase 1 study, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT00005844 is a Phase 1 study that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 26 participants.
The verdict
NCT00005844, a Phase 1 study, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of oxaliplatin in treating children who have advanced solid tumors.
Interventions
- DRUG oxaliplatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2000-04 |
| Est. Completion | 2007-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00005844
The ClinicalTrials.gov registry entry for NCT00005844 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which oxaliplatin is the first listed.
NCT00005844 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00005844 about?
NCT00005844 is a clinical study titled "Oxaliplatin in Treating Children With Advanced Solid Tumors". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of oxaliplatin in treating children who have advanced solid tumors.
What is the current status of trial NCT00005844?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2000-04. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00005844?
The interventions under investigation include: oxaliplatin (DRUG).
Who is sponsoring clinical trial NCT00005844?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.